RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
Ann Clin Biochem 2009;46:73-78
doi:10.1258/acb.2008.008081
© 2009 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jayaraj, R.
Right arrow Articles by Southern, K. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Articles

A reference interval for sweat chloride in infants aged between five and six weeks of age

Rajamanickam Jayaraj1, Paul V Barton2, Paul Newland2, Roger Mountford3, Nigel J Shaw4, Emma Mccarthy3, David M Isherwood2 and Kevin W Southern1


1 Institute of Child Health, University of Liverpool; 2 Department of Clinical Biochemistry, Royal Liverpool Children's Hospital; 3 Department of Clinical Genetics; 4 Department of Neonatal Medicine, Liverpool Women's Hospital, Liverpool, UK


Corresponding author: Dr Kevin W Southern, University of Liverpool, Royal Liverpool Children's Hospital, Eaton Road, Alder Hey, Liverpool L12 2AP, UK. Email: kwsouth{at}liv.ac.uk


Background: This study was designed to establish a reference interval for sweat chloride for infants without evidence of cystic fibrosis (CF), aged between 5 wk and 6 wk, a time when sweat testing is an integral part of newborn screening for CF. In addition, we compared the gold standard method of sweat testing (quantitative pilocarpine iontophoresis [QPIT, coulometry]) with an emerging methodology (MacroductTM [ISE]).

Methods: This was a prospective study on healthy infants at 5–6 wk of age. Sweat collection was undertaken at home on both outer thigh areas using two methods (QPIT and MacroductTM). The order of testing was randomly assigned. Filter paper samples (QPIT) were analysed using flame photometry and coulometry. MacroductTM samples were analysed using ion-selective electrodes (ISE, Abbott Architect c8000, UK).

Results: Insufficient sweat was collected on 28 occasions with the QPIT (coulometry) method and on 31 with the MacroductTM (ISE) capillary system. We achieved a 92% success rate in undertaking two sweat collections consecutively (n = 177). Sweat chloride concentrations were normally distributed with excellent limits of agreement between the two methods of sweat collection and analysis (n = 150). Median (IQR) sweat chloride was 11.2 mmol/L (8–13) with QPIT (coulometry) method with a 99.5th centile (n = 165) of 24 mmol/L.

Conclusion: The MacroductTM (ISE) capillary sweat collection system is valid in this age group. Sweat chloride concentrations above 30 mmol/L should prompt assessment in a specialist CF centre.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor